Zuncheddu Daniele, Buedo Paola, Stoddart Martin J, Creemers Laura B, Grad Sibylle, Waligora Marcin
AO Research Institute Davos Davos Switzerland.
Department of Anesthesiology, MUMC/Mental Health and Neuroscience Research Institute Division Translational Neuroscience Maastricht University Maastricht the Netherlands.
JOR Spine. 2025 Aug 18;8(3):e70104. doi: 10.1002/jsp2.70104. eCollection 2025 Sep.
Intervertebral disc degeneration (IDD) and osteoarthritis (OA) share many similarities in the molecular processes involved in the onset and progression of these musculoskeletal pathologies. Biological sex is a risk factor for both conditions. Sex bias in orthopedic preclinical research affects knowledge, reproducibility, and translational aspects of basic research. This article aims to provide a comprehensive overview of how donor sex is reported in IDD and OA preclinical research using human or animal samples and in vivo models.
We performed a cross-sectional study, searching original articles from journals with the highest impact factor in the field, to determine: (i) whether they report donor sex, and if so, whether they include this data in the analysis; and (ii) whether journals have requirements for sex reporting.
Our research has four main outcomes. First, donor sex was reported in only 61.9% of the 284 cases examined. Second, among the studies where sex was reported (176), samples were predominantly from only male donors or animals (56%). Moreover, sex was rarely incorporated as a variable in outcome analysis (3.4% of cases). Finally, although 14 out of 23 journals stipulated sex reporting requirements, 37.7% of papers published in these journals failed to report donor sex.
Our results provide evidence for the under-reporting of sample donor sex in OA and IDD research, which may contribute to the poor translation to clinical efficacy and the replication crisis. Our findings could guide journal policies, institutional guidelines for preclinical research, and funder requirements.
椎间盘退变(IDD)和骨关节炎(OA)在这些肌肉骨骼疾病的发病和进展所涉及的分子过程中有许多相似之处。生物性别是这两种疾病的一个风险因素。骨科临床前研究中的性别偏见会影响基础研究的知识、可重复性和转化方面。本文旨在全面概述在使用人类或动物样本及体内模型的IDD和OA临床前研究中,样本供体性别是如何报告的。
我们进行了一项横断面研究,检索该领域影响因子最高的期刊上的原始文章,以确定:(i)它们是否报告样本供体性别,如果报告了,是否将该数据纳入分析;以及(ii)期刊是否有性别报告要求。
我们的研究有四个主要结果。第一,在284个研究案例中,只有61.9%报告了样本供体性别。第二,在报告了性别的研究(176项)中,样本主要仅来自雄性供体或动物(56%)。此外,性别很少作为一个变量纳入结果分析(占案例的3.4%)。最后,虽然23本期刊中有14本规定了性别报告要求,但在这些期刊上发表的论文中有37.7%没有报告样本供体性别。
我们的结果为OA和IDD研究中样本供体性别的报告不足提供了证据,这可能导致临床疗效转化不佳和复制危机。我们的研究结果可为期刊政策、临床前研究的机构指南和资助者要求提供指导。